Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive individualized voriconazole dosing study
ISRCTN83902726Phase 2Completed
- Sponsor
- University of Liverpool
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of voriconazole in invasive mycoses, sponsored by University of Liverpool. Primary endpoint: Target voriconazole trough attainment. Started Aug 2014; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ISRCTN83902726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN83902726.